Forward Ventures
Forward Ventures, founded in 1993, has a team of five investment professionals with extensive experience in venture capital and operations. Forward has invested in over 50 companies since it was founded in 1993 and currently has approximately $500 million in capital under management. The most recent fund, Forward V, continues Forward Ventures’ program of life sciences and health care venture investing in companies of all stages. The firm is headquartered in a 40,000 square-foot research building that also serves as an incubator for its portfolio companies.
Recent Milestones
Investments
Videos
Sources
-
Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia (finance.yahoo.com)
[edit]
-
HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing (hemaquest.com)
[edit]
-
Affinium Pharmaceuticals Announces the Closing of $15 Million Financing (afnm.com)
[edit]
-
AMBIT BIOSCIENCES COMPLETES $30 MILLION SERIES D-2 FINANCING (ambitbio.com)
[edit]
-
Nereus Pharmaceuticals, Inc.: Series E $20M (onbiovc.com)
[edit]
-
HemaQuest books $12M Series B to advance mid-stage programs (fiercebiotech.com)
[edit]
-
Syndax Pharmaceuticals, Inc.: Series A $9M (onbiovc.com)
[edit]
-
Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome (tiogapharma.com)
[edit]
-
Altair Therapeutics, Inc.: Series B $17M (onbiovc.com)
[edit]
-
Capital Funding Report
[edit]
-
Asteres Receives $4 Million Additional Financing (venturedeal.com)
[edit]
-
Sanuras, breat tumor device company raises $15M (deals.venturebeat.com)
[edit]
-
EDGAR
[edit]
-
Tiogas Series A Round: $24M For Phase IIb Trial Of IBS Drug (tiogapharma.com)
[edit]
-
Adiana, Inc. Reports Completion of $23 Million Financing. (allbusiness.com)
[edit]